Company Filing History:
Years Active: 2004-2007
Title: Innovations by Inventor Phillip Kish in the Field of Cancer Therapies
Introduction: Phillip Kish, an inventive mind based in Ann Arbor, MI, has made significant contributions to the biomedical field through his innovative patents. With two patents to his name, Kish has focused on creating effective solutions for cellular delivery systems and cancer therapies.
Latest Patents: Phillip Kish’s latest patented inventions include a "Short peptide carrier system for cellular delivery of agent" and "Treatments and markers for cancers of the central nervous system". The peptide carrier system patent describes a formulation that utilizes a dipeptide or tripeptide carrier for delivering active agents such as therapeutics, fluorescent dyes, or contrast agents to cells, specifically with a molecular weight of less than 500 atomic mass units. This system is designed for oral administration and incorporates an optional linker to enhance the delivery mechanism. The second patent addresses novel cancer markers and therapeutic methods, providing compositions and techniques for detecting gene expression in cancers, specifically glioma, which could pave the way for new intervention strategies in cancer therapies.
Career Highlights: Phillip Kish has worked at prominent institutions that foster innovation, including Tsrl, Inc. and the University of Michigan. His experiences at these organizations have played a pivotal role in his development as an inventor and researcher in the biomedical sector.
Collaborations: Throughout his career, Phillip Kish has collaborated with accomplished professionals, including John Hilfinger and Samir M Hanash. These partnerships have likely contributed to the depth and breadth of his research and patent developments.
Conclusion: Phillip Kish stands out as a notable inventor within the realm of biomedical innovations. His work, particularly in cancer therapy and cellular delivery systems, showcases his commitment to advancing medical sciences and improving patient outcomes. As he continues to innovate, Kish’s patents pave the way for future advancements in the field.